Wholesale of pharmaceutical and medical goods
BIOMERIEUX NORGE AS
Revenue 2024
NOK 74.3m
Operating profit
NOK 3.6m
Equity
NOK 6.4m
Incorporated
1999
Share capital
NOK 2.8m
Key figures · 2024
Current ratio
1.11
Equity ratio
28.2%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 4.8% | |
| Net margin (%%) | 4.2% | |
| Return on assets (%%) | 15.8% | |
| Likviditet | ||
| Current ratio | 1.11 | |
| Working capital | 1.7m | |
| Soliditet | ||
| Equity ratio (%%) | 28.2% | |
| Debt-to-equity ratio | 2.55 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.